BioSpace News Archive

Passage Bio, Inc., a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, announced that management will participate in three upcoming virtual investor conferences in April

AGTC’s deep commitment to the patient voice drives solutions to support patient access to information and to improve the experience of patients participating in clinical trials

MatriSys Bioscience, a company harnessing beneficial bacteria to treat inflammatory skin diseases, announced the hiring of Joyce Rico, MD, MBA, FAAD, as Chief Medical Officer.

Annexon, Inc., a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye, announced fourth quarter and full-year 2020 financial results and business highlights.

Initiated multiple early-stage clinical trials evaluating its oral SERD, ZN-c5, WEE1 inhibitor, ZN-c3 and BCL-2 inhibitor, ZN-d5

Continued progress in OVAL Phase 3 registration enabling study investigating VB-111 in patients with platinum-resistant ovarian cancer; high CA-125 response rates (RR) of over 50% in the total evaluable patient population with more than200 patients enrolled to date.

Preclinical data demonstrates the potential of BiSKITsTM (Bi-functional SuperKine ImmunoTherapies) to effectively target immunologically “cold” tumors

Cipher Pharmaceuticals Inc. announced that it has received approval from the Toronto Stock Exchange to amend its normal course issuer bid in order to enter into an automatic repurchase plan with its designated broker.

Centene Corporation announced its Hawaii subsidiary ‘Ohana Health Plan was selected by the Hawaii Department of Human Services’ Med-QUEST Division to continue administering covered services to eligible Medicaid and Children’s Health Insurance Program members for medically necessary medical, behavioral health, and long-term services and supports.

ACG, a leading supplier of fully integrated solutions to the global pharmaceutical and nutraceutical industry, is delighted to announce its new ACGcaps™ NTone and ACGcaps™ TSafe range of capsules for the Nutraceutical market.